title: Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse.
abstract: High risk human papillomaviruses (HPVs) have emerged as risk factors for anal carcinoma, of which incidence is higher in HIV-positive patients than in the general population. The aim of our study was to investigate the prevalence and risk factors for anal HPV infections in HIV-positive patients with or without history of anal intercourse. Fifty HIV 1-infected patients (36 men and 14 women) were tested at entry and followed-up every 3 months for one year for the presence of anal HPV DNA by the Hybrid Capture II trade mark assay. A series of 50 HIV-negative subjects matched for age and sex served as controls. At enrollment, anal HPV DNA was present in 29/50 HIV-positive patients (58 %) and in 3/50 control subjects (6 %). High risk (HR) HPV genotypes were detected in 20/50 HIV-positive patients (40 %) with no difference in homosexual men and other HIV-positive patients. Risk factors for HPV infection were CD4 + cell counts less than 500/microL (RR: 2.13 [95 % CI: 1.0-4.7]) and history of anogenital warts (RR: 2.36 [95 % CI: 1.2-4.6]). The HPV load was higher in patients with CD4+ < or = 500/microL than in patients with CD4 + > 500/microL (p < 0.04). During the follow-up, anal HR HPV DNA was repeatedly identified at high levels in 5 HIV-positive patients. There is some convincing evidence that HIV-positive patients with low CD4+ cells, whatever the routes of HIV transmission, have a high rate of anal HPV infection and might be at increased risk of developing anal neoplastic lesions. Identifying HR HPV infection might be warranted in immunosuppressed patients.
authors.affiliation: Service de Dermatologie, CHU, 25000 Besançon, France.
authors.forename: C
authors.initials: C
authors.lastname: Drobacheff
authors.forename: P
authors.initials: P
authors.lastname: Dupont
authors.forename: C
authors.initials: C
authors.lastname: Mougin
authors.forename: Y
authors.initials: Y
authors.lastname: Bourezane
authors.forename: B
authors.initials: B
authors.lastname: Challier
authors.forename: M
authors.initials: M
authors.lastname: Fantoli
authors.forename: D
authors.initials: D
authors.lastname: Bettinger
authors.forename: R
authors.initials: R
authors.lastname: Laurent
mesh_terms: D000328:Adult; D001004:Anus Diseases / Q000453:epidemiology* / Q000209:etiology; D018791:CD4 Lymphocyte Count; D016022:Case-Control Studies; D004279:DNA, Viral / Q000032:analysis*; D005260:Female; D005602:France / Q000453:epidemiology; D015658:HIV Infections; D006801:Humans; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000235:genetics* / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D012307:Risk Factors; D012725:Sexual Behavior; D014412:Tumor Virus Infections / Q000453:epidemiology* / Q000209:etiology
chemical_list: D004279:DNA, Viral